Sotatercept in Pulmonary Arterial Hypertension

NCT07140484 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Artery Hypertension

Interventions

DRUG: Sotatercept

Sponsor

University of Alberta

Collaborators

[object Object]
[object Object]